Used as an anticoagulant to prevent blood clots in patients undergoing treatment for deep vein thrombosis and pulmonary embolism. Also prescribed to reduce the risk of stroke and systemic embolism in individuals with non-valvular atrial fibrillation. It works by selectively inhibiting Factor Xa, a key component in the blood coagulation cascade. The p-toluenesulfonate salt form enhances solubility and bioavailability, supporting consistent oral dosing with predictable pharmacokinetics. Commonly used in long-term outpatient settings due to its fixed dosing regimen and lower need for routine coagulation monitoring.